Company Profile

Adarza BioSystems Inc (AKA: Pathologics Llc~Patholgic Associates)
Profile last edited on: 2/21/2020      CAGE: 36YL7      UEI: M5SMNYM6D7K9

Business Identifier: Biiological assay platform for measuring clinical and point-of-care samples
Year Founded
2007
First Award
2005
Latest Award
2013
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2184 Welsch Industrial Court
St. Louis, MO 63146
   (314) 925-7800
   info@adarzabio.com
   www.adarzabio.com
Location: Multiple
Congr. District: 01
County: St. Louis

Public Profile

Formerly known as Pathologics, LLC, Adarza BioSystems, Inc is an early stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. With the underpinning technology licensed from University of Rochester Medical Center, while still maintaing a NY state presence, headquartrers of the firm is now moved to St Louis, MO. In addition to performing sophisticated clinical tests within minutes, the firm's technology is fully arrayable, potentially allowing hundreds of tests to be run simultaneously on a single chip. Sample antibody array AIR image taken on the Adarza BioSystems, Inc prototype optical reader. Spot size is ~100┬Ám This proprietary platform technology will enable not only the next generation of clinical devices, but will revolutionize the medical diagnostics field. Ultimately, we envision this technology driving a broad range of devices from future in-home diagnostics where the patient will self-diagnose illness with minimal physician input, to large-scale customizable research grade instrumentation. Adarza's proprietary chip-based platform, Arrayed Imaging Reflectometry (AIR), achieves high sensitivity by detecting intensity changes in images of antireflective chips functionalized with highly specific detection molecules (proteins, DNA, etc.).

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Rand Henke -- Founder and Chief Executive Officer

  Terry Gronwall -- Chief Operating Officer

  Scott R Horner

  Preston Keller -- Vice President of Business Development

  Benjamin L Miller

  Ernest Mueller -- Director of Operations

  George Perzel -- Managing Director

  Christopher Striemer -- VP - Engineering